Rentschler Biopharma Contract Manufacturing & Development (CDMO) Profile
At Rentschler Biopharma, reliability you can trust is more than a promise—it’s our commitment.
As a global leader in Contract Development and Manufacturing Organization (CDMO) services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023.
CDMO Services:
Biologics; Cell & Gene Therapy
Year Founded: 1872
Head Office: Laupheim, Germany
Number of Facilities: 3-5
Facility locations: Europe; North America
Website: Visit the Rentschler Biopharma website
Linkedin: Connect on Linkedin